Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1353505

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has for a covid-19 vaccine booster campaign in autumn 2021.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	44364
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021, which can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI’s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine, and flu vaccine, as soon as possible from September, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster programme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply and approvals by the Medicines and Healthcare products Regulatory Agency.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:46:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4385 label Biography information for Dr Philippa Whitford

1352871

registered interest
date	06/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many covid-19 vaccines have been disposed of that were (a) out of date (b) unused to date.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	43653
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The information requested is not currently centrally held. Work is ongoing across the vaccination programme to standardise and increase the information available for management purposes.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 11:00:27 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4658 label Biography information for Alex Sobel

1352957

registered interest
date	06/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what evidence his Department holds on the potential benefits of immunisation against covid-19 for people who have previously tested positive for that virus.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	43644
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>It is not known how long antibodies made in response to natural COVID-19 infection persist, and whether immunisation could offer more protection. However, it is expected the COVID-19 vaccine would boost any pre-existing antibodies from previous infection. There is no evidence of any safety concerns from vaccinating individuals with a history of COVID-19 infection or with detectable antibodies to COVID-19. Therefore, people who have had COVID-19 disease – whether confirmed or suspected – should still receive the COVID-19 vaccine.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 09:12:09 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4645 label Biography information for Emma Hardy

1353027

registered interest
date	06/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the data and evidential basis which supports the decision of the Joint Committee on Vaccination and Immunisation to authorise administration of a covid-19 vaccine to people aged 16 and 17.
tabling member constituency	Gateshead
tabling member printed	Ian Mearns
uin	43491
answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s advice on vaccination of those aged 16 to 17 years old was published on 4 August 2021. The statement sets out the basis for the advice and includes references to supporting evidence and is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years" target="_blank">https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 16:39:03 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4000 label Biography information for Ian Mearns

1353036

registered interest
date	06/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Covid Pass
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with relevant stakeholders to help ensure that people who received doses of the AstraZeneca covid-19 vaccine produced in India are able to demonstrate their vaccination status when travelling overseas.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	43526
answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government continues to liaise with international partners and other organisations, such as the International Civil Aviation Organization and the World Health Organization, to support the work on certification to ensure that global travel is unhindered and supported by a common approach.</p><p>All doses of AstraZeneca COVID-19 vaccines manufactured in India and administered in the United Kingdom are the same product, under the same authorisation as all other AstraZeneca vaccine doses deployed in the UK, now known commercially Vaxzevria. They appear on the NHS COVID Pass as such, which has been available for international travel since May. Decisions on which vaccines countries will accept at their borders are for respective Governments and we continue to actively engage with these countries to ensure all AstraZeneca doses administered in the UK, including those manufactured in India, are recognised.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 16:41:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4267 label Biography information for Sarah Champion

1353044

registered interest
date	06/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of prison inmates have been (a) offered a covid-19 vaccine and (b) vaccinated against covid-19.
tabling member constituency	Lewisham West and Penge
tabling member printed	Ellie Reeves
uin	43638
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>All eligible prisoners in England have been offered a COVID-19 vaccine and according to the latest available data, 44% are now fully vaccinated with two doses. This includes 80% of those over 50 years old and 37% of the under 50 year old population.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 16:30:50 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4620 label Biography information for Ellie Reeves

1352517

registered interest
date	03/09/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many doses of covid-19 vaccine the UK has received from Covax for each month since Covax has been in operation; for what reasons the UK has received doses through Covax; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	41806
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The UK committed approximately £71 million to the self-financing facility of COVAX, which enables high and upper-middle income countries to pool investments in potential vaccine candidates, and supported its establishment last year. This gives us the option to buy vaccines for up to 20% of the UK population - approximately 27 million doses. The Government has separately committed £548 million to the COVAX Advance Market Commitment, which will distribute 1.2 billion doses of vaccines to developing countries this year.</p><p> </p><p>In addition, I am proud that as part of our commitment to the G7 to donate 100m doses over the course of the next year, the UK has so far donated over 10 million doses to those countries most in need, of which over 6 million have gone to COVAX. Throughout the COVID-19 vaccination programme, vaccine supply and deliveries have been carefully managed by the Vaccine Taskforce to meet the requirements of the domestic vaccination programme as well as support other countries’ domestic campaigns. The recent sharing of 4 million doses with Australia is a good example of this.</p><p> </p><p>I refer the Hon. Member to the answer I gave her on 3rd March 2021 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2021-02-23/157070" target="_blank">157070</a>: the UK procured approximately 0.5 million doses of the Pfizer vaccine through COVAX, which were delivered earlier this year. These doses helped the NHS deliver our vaccination programme as quickly as possible. No further doses have been received by the UK from COVAX.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 13:04:33 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1350957

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce covid-19 vaccine wastage; and what action is taken with unused vaccines.
tabling member constituency	Birmingham, Ladywood
tabling member printed	Shabana Mahmood
uin	40820
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No vaccines should be wasted. All vaccination centres should have a backup list of people in the cohorts currently being vaccinated, who can be called in case doses would be wasted. This is in line with the Enhanced Service Specification for the COVID-19 vaccination programme 2020/21.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction, including, where there is data to support it, looking at the extension of expiry dates.</p><p>The United Kingdom is also one of the largest donors to COVID-19 Vaccines Global Access (COVAX). We will donate at least 100 million surplus doses within the next year, with the first batch of five million already delivered last month.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:43:56 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3914 label Biography information for Shabana Mahmood

1350995

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people who have received two covid-19 vaccinations, including Oxford AstraZeneca batch numbers (a) 4120Z001, (b) 4120Z002 and (c) 4120Z003, are able to travel to EU countries.
tabling member constituency	Halifax
tabling member printed	Holly Lynch
uin	41025
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The European Union has recently published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency, for travel purposes which is at the following link:</p><p> </p><p><a href="https://reopen.europa.eu/en" target="_blank">https://reopen.europa.eu/en</a></p><p> </p><p>The list includes all vaccines administered in the United Kingdom, including all batches of AstraZeneca vaccine administered in the UK known commercially as Vaxzevria. This also includes batches 4120Z001, 4120Z002 and 4120Z003. Decisions on which vaccines EU Member States will accept at their borders is for those countries to decide. We are not aware that any have decided not to accept UK vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:15:23 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4472 label Biography information for Holly Lynch

1351014

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with its counterpart in Italy in respect of British tourists' entry to Italy whose covid-19 vaccine was manufactured at Serum Institute in India.
tabling member constituency	Meriden
tabling member printed	Saqib Bhatti
uin	41357
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield vaccines and both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the United Kingdom (UK) regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’.</p><p> </p><p>The government continues to liaise with counterparts in Italy and we are seeking Italian confirmation that they will recognise all AstraZeneca doses administered in the UK. We will ensure that Foreign, Commonwealth and Development Office Travel Advice is kept up to date following any developments.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:10:14 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4818 label Biography information for Saqib Bhatti